Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study
Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological e...
Ausführliche Beschreibung
Autor*in: |
Chidini, Giovanna [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2023 |
---|
Schlagwörter: |
---|
Anmerkung: |
© The Author(s) 2023 |
---|
Übergeordnetes Werk: |
Enthalten in: Intensive Care Medicine – Paediatric and Neonatal - Springer International Publishing, 2023, 1(2023), 1 vom: 03. Aug. |
---|---|
Übergeordnetes Werk: |
volume:1 ; year:2023 ; number:1 ; day:03 ; month:08 |
Links: |
---|
DOI / URN: |
10.1007/s44253-023-00013-2 |
---|
Katalog-ID: |
SPR05263700X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR05263700X | ||
003 | DE-627 | ||
005 | 20231121064930.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230804s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s44253-023-00013-2 |2 doi | |
035 | |a (DE-627)SPR05263700X | ||
035 | |a (SPR)s44253-023-00013-2-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chidini, Giovanna |e verfasserin |0 (orcid)0000-0002-3807-1184 |4 aut | |
245 | 1 | 0 | |a Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2023 | ||
520 | |a Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018. | ||
650 | 4 | |a Non-invasive ventilation |7 (dpeaa)DE-He213 | |
650 | 4 | |a High-flow nasal cannulas |7 (dpeaa)DE-He213 | |
650 | 4 | |a Bronchiolitis |7 (dpeaa)DE-He213 | |
700 | 1 | |a Mauri, Tommaso |4 aut | |
700 | 1 | |a Conti, Giorgio |4 aut | |
700 | 1 | |a Catenacci, Stefano Scalia |4 aut | |
700 | 1 | |a Marchesi, Tiziana |4 aut | |
700 | 1 | |a Dona, Giada |4 aut | |
700 | 1 | |a Figini, Maria Adele |4 aut | |
700 | 1 | |a Babini, Giovanni |4 aut | |
700 | 1 | |a Calderini, Edoardo |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Intensive Care Medicine – Paediatric and Neonatal |d Springer International Publishing, 2023 |g 1(2023), 1 vom: 03. Aug. |w (DE-627)1839534869 |x 2731-944X |7 nnns |
773 | 1 | 8 | |g volume:1 |g year:2023 |g number:1 |g day:03 |g month:08 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s44253-023-00013-2 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 1 |j 2023 |e 1 |b 03 |c 08 |
author_variant |
g c gc t m tm g c gc s s c ss ssc t m tm g d gd m a f ma maf g b gb e c ec |
---|---|
matchkey_str |
article:2731944X:2023----::hsooiaefcsftnadxgnhrphgfonslanlademtppnctboci |
hierarchy_sort_str |
2023 |
publishDate |
2023 |
allfields |
10.1007/s44253-023-00013-2 doi (DE-627)SPR05263700X (SPR)s44253-023-00013-2-e DE-627 ger DE-627 rakwb eng Chidini, Giovanna verfasserin (orcid)0000-0002-3807-1184 aut Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018. Non-invasive ventilation (dpeaa)DE-He213 High-flow nasal cannulas (dpeaa)DE-He213 Bronchiolitis (dpeaa)DE-He213 Mauri, Tommaso aut Conti, Giorgio aut Catenacci, Stefano Scalia aut Marchesi, Tiziana aut Dona, Giada aut Figini, Maria Adele aut Babini, Giovanni aut Calderini, Edoardo aut Enthalten in Intensive Care Medicine – Paediatric and Neonatal Springer International Publishing, 2023 1(2023), 1 vom: 03. Aug. (DE-627)1839534869 2731-944X nnns volume:1 year:2023 number:1 day:03 month:08 https://dx.doi.org/10.1007/s44253-023-00013-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2023 1 03 08 |
spelling |
10.1007/s44253-023-00013-2 doi (DE-627)SPR05263700X (SPR)s44253-023-00013-2-e DE-627 ger DE-627 rakwb eng Chidini, Giovanna verfasserin (orcid)0000-0002-3807-1184 aut Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018. Non-invasive ventilation (dpeaa)DE-He213 High-flow nasal cannulas (dpeaa)DE-He213 Bronchiolitis (dpeaa)DE-He213 Mauri, Tommaso aut Conti, Giorgio aut Catenacci, Stefano Scalia aut Marchesi, Tiziana aut Dona, Giada aut Figini, Maria Adele aut Babini, Giovanni aut Calderini, Edoardo aut Enthalten in Intensive Care Medicine – Paediatric and Neonatal Springer International Publishing, 2023 1(2023), 1 vom: 03. Aug. (DE-627)1839534869 2731-944X nnns volume:1 year:2023 number:1 day:03 month:08 https://dx.doi.org/10.1007/s44253-023-00013-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2023 1 03 08 |
allfields_unstemmed |
10.1007/s44253-023-00013-2 doi (DE-627)SPR05263700X (SPR)s44253-023-00013-2-e DE-627 ger DE-627 rakwb eng Chidini, Giovanna verfasserin (orcid)0000-0002-3807-1184 aut Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018. Non-invasive ventilation (dpeaa)DE-He213 High-flow nasal cannulas (dpeaa)DE-He213 Bronchiolitis (dpeaa)DE-He213 Mauri, Tommaso aut Conti, Giorgio aut Catenacci, Stefano Scalia aut Marchesi, Tiziana aut Dona, Giada aut Figini, Maria Adele aut Babini, Giovanni aut Calderini, Edoardo aut Enthalten in Intensive Care Medicine – Paediatric and Neonatal Springer International Publishing, 2023 1(2023), 1 vom: 03. Aug. (DE-627)1839534869 2731-944X nnns volume:1 year:2023 number:1 day:03 month:08 https://dx.doi.org/10.1007/s44253-023-00013-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2023 1 03 08 |
allfieldsGer |
10.1007/s44253-023-00013-2 doi (DE-627)SPR05263700X (SPR)s44253-023-00013-2-e DE-627 ger DE-627 rakwb eng Chidini, Giovanna verfasserin (orcid)0000-0002-3807-1184 aut Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018. Non-invasive ventilation (dpeaa)DE-He213 High-flow nasal cannulas (dpeaa)DE-He213 Bronchiolitis (dpeaa)DE-He213 Mauri, Tommaso aut Conti, Giorgio aut Catenacci, Stefano Scalia aut Marchesi, Tiziana aut Dona, Giada aut Figini, Maria Adele aut Babini, Giovanni aut Calderini, Edoardo aut Enthalten in Intensive Care Medicine – Paediatric and Neonatal Springer International Publishing, 2023 1(2023), 1 vom: 03. Aug. (DE-627)1839534869 2731-944X nnns volume:1 year:2023 number:1 day:03 month:08 https://dx.doi.org/10.1007/s44253-023-00013-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2023 1 03 08 |
allfieldsSound |
10.1007/s44253-023-00013-2 doi (DE-627)SPR05263700X (SPR)s44253-023-00013-2-e DE-627 ger DE-627 rakwb eng Chidini, Giovanna verfasserin (orcid)0000-0002-3807-1184 aut Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018. Non-invasive ventilation (dpeaa)DE-He213 High-flow nasal cannulas (dpeaa)DE-He213 Bronchiolitis (dpeaa)DE-He213 Mauri, Tommaso aut Conti, Giorgio aut Catenacci, Stefano Scalia aut Marchesi, Tiziana aut Dona, Giada aut Figini, Maria Adele aut Babini, Giovanni aut Calderini, Edoardo aut Enthalten in Intensive Care Medicine – Paediatric and Neonatal Springer International Publishing, 2023 1(2023), 1 vom: 03. Aug. (DE-627)1839534869 2731-944X nnns volume:1 year:2023 number:1 day:03 month:08 https://dx.doi.org/10.1007/s44253-023-00013-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2023 1 03 08 |
language |
English |
source |
Enthalten in Intensive Care Medicine – Paediatric and Neonatal 1(2023), 1 vom: 03. Aug. volume:1 year:2023 number:1 day:03 month:08 |
sourceStr |
Enthalten in Intensive Care Medicine – Paediatric and Neonatal 1(2023), 1 vom: 03. Aug. volume:1 year:2023 number:1 day:03 month:08 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Non-invasive ventilation High-flow nasal cannulas Bronchiolitis |
isfreeaccess_bool |
true |
container_title |
Intensive Care Medicine – Paediatric and Neonatal |
authorswithroles_txt_mv |
Chidini, Giovanna @@aut@@ Mauri, Tommaso @@aut@@ Conti, Giorgio @@aut@@ Catenacci, Stefano Scalia @@aut@@ Marchesi, Tiziana @@aut@@ Dona, Giada @@aut@@ Figini, Maria Adele @@aut@@ Babini, Giovanni @@aut@@ Calderini, Edoardo @@aut@@ |
publishDateDaySort_date |
2023-08-03T00:00:00Z |
hierarchy_top_id |
1839534869 |
id |
SPR05263700X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR05263700X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20231121064930.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230804s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s44253-023-00013-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR05263700X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s44253-023-00013-2-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chidini, Giovanna</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-3807-1184</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2023</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Non-invasive ventilation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High-flow nasal cannulas</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bronchiolitis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mauri, Tommaso</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Conti, Giorgio</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Catenacci, Stefano Scalia</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marchesi, Tiziana</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dona, Giada</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Figini, Maria Adele</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Babini, Giovanni</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calderini, Edoardo</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Intensive Care Medicine – Paediatric and Neonatal</subfield><subfield code="d">Springer International Publishing, 2023</subfield><subfield code="g">1(2023), 1 vom: 03. Aug.</subfield><subfield code="w">(DE-627)1839534869</subfield><subfield code="x">2731-944X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">day:03</subfield><subfield code="g">month:08</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s44253-023-00013-2</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="b">03</subfield><subfield code="c">08</subfield></datafield></record></collection>
|
author |
Chidini, Giovanna |
spellingShingle |
Chidini, Giovanna misc Non-invasive ventilation misc High-flow nasal cannulas misc Bronchiolitis Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study |
authorStr |
Chidini, Giovanna |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1839534869 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
2731-944X |
topic_title |
Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study Non-invasive ventilation (dpeaa)DE-He213 High-flow nasal cannulas (dpeaa)DE-He213 Bronchiolitis (dpeaa)DE-He213 |
topic |
misc Non-invasive ventilation misc High-flow nasal cannulas misc Bronchiolitis |
topic_unstemmed |
misc Non-invasive ventilation misc High-flow nasal cannulas misc Bronchiolitis |
topic_browse |
misc Non-invasive ventilation misc High-flow nasal cannulas misc Bronchiolitis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Intensive Care Medicine – Paediatric and Neonatal |
hierarchy_parent_id |
1839534869 |
hierarchy_top_title |
Intensive Care Medicine – Paediatric and Neonatal |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1839534869 |
title |
Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study |
ctrlnum |
(DE-627)SPR05263700X (SPR)s44253-023-00013-2-e |
title_full |
Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study |
author_sort |
Chidini, Giovanna |
journal |
Intensive Care Medicine – Paediatric and Neonatal |
journalStr |
Intensive Care Medicine – Paediatric and Neonatal |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2023 |
contenttype_str_mv |
txt |
author_browse |
Chidini, Giovanna Mauri, Tommaso Conti, Giorgio Catenacci, Stefano Scalia Marchesi, Tiziana Dona, Giada Figini, Maria Adele Babini, Giovanni Calderini, Edoardo |
container_volume |
1 |
format_se |
Elektronische Aufsätze |
author-letter |
Chidini, Giovanna |
doi_str_mv |
10.1007/s44253-023-00013-2 |
normlink |
(ORCID)0000-0002-3807-1184 |
normlink_prefix_str_mv |
(orcid)0000-0002-3807-1184 |
title_sort |
physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet cpap in acute bronchiolitis: a randomized cross-over study |
title_auth |
Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study |
abstract |
Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018. © The Author(s) 2023 |
abstractGer |
Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018. © The Author(s) 2023 |
abstract_unstemmed |
Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018. © The Author(s) 2023 |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
1 |
title_short |
Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study |
url |
https://dx.doi.org/10.1007/s44253-023-00013-2 |
remote_bool |
true |
author2 |
Mauri, Tommaso Conti, Giorgio Catenacci, Stefano Scalia Marchesi, Tiziana Dona, Giada Figini, Maria Adele Babini, Giovanni Calderini, Edoardo |
author2Str |
Mauri, Tommaso Conti, Giorgio Catenacci, Stefano Scalia Marchesi, Tiziana Dona, Giada Figini, Maria Adele Babini, Giovanni Calderini, Edoardo |
ppnlink |
1839534869 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1007/s44253-023-00013-2 |
up_date |
2024-07-03T13:42:03.573Z |
_version_ |
1803565529644924928 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR05263700X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20231121064930.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230804s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s44253-023-00013-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR05263700X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s44253-023-00013-2-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chidini, Giovanna</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-3807-1184</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Physiological effects of standard oxygen therapy, high-flow nasal cannula, and helmet CPAP in acute bronchiolitis: a randomized cross-over study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2023</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objectives Acute viral bronchiolitis (AVB) is a major cause of hospitalization for children in developed and developing countries. Nasal high flow (NHF) therapy improves oxygenation and reduces respiratory drive by enhancing carbon dioxide wash-out. However, little is known about the physiological effects of non-invasive helmet continuous positive airway pressure (h-CPAP) and NHF on respiratory work of breathing (WOB) in pediatric patients with AVB. The present study measured esophageal pressure time product over 1 min (PTPes*$ min^{−1} $), as a close surrogate for WOB during standard oxygen therapy (SOT), NHF delivered at incremental flow rates, and h-CPAP in hospitalized patients with AVB. Methods This is a physiological randomized crossover study with four 20-min steps: SOT delivered by a Venturi mask; NHF2 set at 2L/kg*$ min^{−1} $PBW; NHF3 set at 3L/kg*$ min^{−1} $PBW; and h-CPAP with PEEP 7 $ cmH_{2} $O. PTPes *$ min^{−1} $, pressure rate product (PRP), respiratory and other physiological parameters were collected towards the end of each step. Results Ten hypoxemic children with AVB were enrolled. PTPes*$ min^{−1} $, respiratory rate (RR), PRP, and heart rate (HR) decreased progressively from h-CPAP to NHF3, NHF2, and SOT (p < 0.01). Transcutaneous carbon dioxide tension ($ tcCO_{2} $) was lower during h-CPAP, NHF3, and NHF2 than during SOT (p < 0.001). $ SpO_{2} $:$ FiO_{2} $ was higher during h-CPAP than with all other support (p < 0.01). Conclusions In pediatric patients with AVB, h-CPAP was associated with lower WOB, better oxygenation, and lower $ tcCO_{2} $ than with SOT and NHF trials. Trial registration Clinicaltrials.gov NCT03689686 Registered 1 August 2018.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Non-invasive ventilation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High-flow nasal cannulas</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bronchiolitis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mauri, Tommaso</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Conti, Giorgio</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Catenacci, Stefano Scalia</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marchesi, Tiziana</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dona, Giada</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Figini, Maria Adele</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Babini, Giovanni</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calderini, Edoardo</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Intensive Care Medicine – Paediatric and Neonatal</subfield><subfield code="d">Springer International Publishing, 2023</subfield><subfield code="g">1(2023), 1 vom: 03. Aug.</subfield><subfield code="w">(DE-627)1839534869</subfield><subfield code="x">2731-944X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">day:03</subfield><subfield code="g">month:08</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s44253-023-00013-2</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="b">03</subfield><subfield code="c">08</subfield></datafield></record></collection>
|
score |
7.4027443 |